𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine

✍ Scribed by Maria Planck; Kajsa Ericson; Zofia Piotrowska; Britta Halvarsson; Eva Rambech; Mef Nilbert


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
360 KB
Volume
97
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

Carcinomas of the small intestine are rare, but the risk is greatly increased in patients with hereditary nonpolyposis colorectal cancer (hnpcc) due to an inherited mismatch repair (mmr) gene mutation, most commonly affecting the genes mlh1 or msh2. defective mmr is characterized by microsatellite instability (msi) and loss of mmr protein expression in the tumor tissue. however, a subset of several sporadic tumor types, including about 15% of colon cancers, also evolve through defective mmr.

Methods:

The authors have assessed the frequency of msi and analyzed the immunohistochemical expression of mlh1 and msh2 in a population-based series of 89 adenocarcinomas of the small intestine. to study the contribution of msi and defective mmr protein expression in young patients, 43 cancers of the small intestine from patients below age 60 years (including 24 tumors from the population-based series and an additional 19 tumors from young individuals) were also analyzed.

Results:

Msi was detected in 16/89 tumors (18%) in the population-based series, and immunohistochemistry revealed loss of expression for mlh1 in 7/16 msi tumors and in 2/73 mss tumors, whereas all tumors showed normal expression for msh2. among the young patients, the authors identified msi in 10/43 tumors (23%), and 6 of these 10 msi tumors showed immunohistochemical loss of mmr protein expression, which affected mlh1 in 3 cases and msh2 in 3 cases.

Conclusions:

The frequency of msi (18%) in adenocarcinomas of the small intestine equals that of colon cancer. however, silencing of mlh1 seems to explain the msi status in only about half of the msi tumors. among patients with cancer of the small intestine before age 60 years, msi is found in 23% of the cases, with mlh1 and msh2 being affected at equal frequencies, indicating that hnpcc may underly a subset of such cases.


πŸ“œ SIMILAR VOLUMES


Promoter methylation and expression of M
✍ JΓΆrg Felsberg; Niklas Thon; Sabina Eigenbrod; Bettina Hentschel; Michael C. Sabe πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 534 KB

## Abstract Epigenetic silencing of the O^6^‐methylguanine‐DNA methyltransferase (__MGMT__) gene promoter is associated with prolonged survival in glioblastoma patients treated with temozolomide (TMZ). We investigated whether glioblastoma recurrence is associated with changes in the promoter methyl

Identification of six novel MSH2 and MLH
✍ Stefan KrΓΌger; Jens Plaschke; Birgit Jeske; Heike GΓΆrgens; Steffen R. Pistorius; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 40 KB πŸ‘ 2 views

Germline mutations in mismatch repair genes are responsible for hereditary nonpolyposis colorectal cancer (HNPCC), the most common hereditary cancer-susceptibility syndrome. We report six novel germline mutations, three in MSH2 and three in MLH1. All but one mutation have been found in families fulf

Microsatellite instability and hMLH1/hMS
✍ Yann R. Parc; Kevin C. Halling; Larry J. Burgart; Shannon K. McDonnell; Daniel J πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 556 KB

Endometrial cancer is the second most common malignancy in patients with hereditary nonpolyposis colorectal cancer (HNPCC). The age at diagnosis of HNPCC-associated endometrial cancer is approximately 15 years younger than for sporadic endometrial cancer. Our current study was undertaken to determin

Mutational analysis of MLH1 and MSH2 in
✍ Lynn D. Kowalski; David G. Mutch; Thomas J. Herzog; Janet S. Rader; Paul J. Good πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 227 KB πŸ‘ 2 views

Mutations in the DNA mismatch repair (MMR) genes MLH1 and MSH2 have been linked to several human cancers which display the replication error (RER) phenotype. Germline mutations in these two genes have been implicated in about 90% of families with hereditary nonpolyposis colorectal cancer (HNPCC). A